Cabozantinib

• Description:

  Cabozantinib (XL184, BMS-907351) is a potent multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  501.5057

• Molecular Formula:

  C28H24FN3O5

• Notes:

  Research use only, not for human use.

• Receptor:

  AXL|c-Met|Kit|VEGFR2/KDR|VEGFR3/FLT4|VEGFR2|MET|MET (Y1248H) |RET|FLT3

• CAS Number:

  849217-68-1